Company intelligence / Profile preview

Bionanofiber

Ansan-si, Gyeonggi-do, South Koreabionanofiber.com ↗

Ownership: Private
Development stage: Other

Overview

Bionanofiber is a South Korean biotechnology company specializing in the development and manufacturing of advanced nanofiber materials for medical and industrial applications. The company utilizes its proprietary electrospinning technology to produce high-performance nanofibers used in wound dressings, surgical masks, and air filtration systems. Their products are designed to provide superior breathability, filtration efficiency, and biocompatibility compared to traditional materials. Bionanofiber's medical-grade materials are aimed at improving patient outcomes in wound care and providing high-level protection in healthcare settings through innovative filtration solutions.

Therapeutic areas: PulmonologyDermatologyInfectious Diseases
Modalities: NanoparticleDeviceBiomaterials
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Bionanofiber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionanofiber.